MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway

Xuemei He1, Yingqiang Zheng2, Shengzhi Liu3

  • 1Experimental Medicine Center, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Insights

MicroRNA-146a (miR-146a) levels decrease in small intestine ischemia-reperfusion (I/R) injury. Upregulating miR-146a protects intestinal epithelial cells by inhibiting the TLR4/TRAF6/NF-κB pathway, improving survival.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Cell Biology

Background:

  • Small intestine ischemia-reperfusion (I/R) injury is a critical condition with significant morbidity.
  • The precise molecular mechanisms underlying I/R injury, particularly the role of microRNAs, remain incompletely understood.
  • Previous research suggested a role for microRNA-146a (miR-146a) in I/R injury, but its functional mechanism was unclear.

Purpose of the Study:

  • To investigate the expression levels of miR-146a in patients with mesenteric ischemia.
  • To elucidate the regulatory role and mechanism of miR-146a in intestinal epithelial cell survival during ischemia and I/R injury.
  • To explore the potential therapeutic implications of modulating miR-146a in I/R injury.

Main Methods:

  • Quantitative real-time PCR (qPCR) was used to measure miR-146a expression in plasma from patients and in rat intestinal epithelial cells (IEC-6) and tissues.
  • In vitro and in vivo models of intestinal ischemia and I/R were established using IEC-6 cells and Sprague-Dawley rats.
  • Western blotting and immunofluorescence were employed to assess protein expression and cellular localization, including cleaved-caspase 3, TLR4, TRAF6, NF-κB p65, XIAP, and SOCS3.

Main Results:

  • miR-146a expression was significantly decreased in the plasma of mesenteric ischemia patients and in intestinal tissues/cells subjected to ischemia and I/R.
  • Ischemia-reperfusion induced more severe apoptotic injury than ischemia alone, characterized by increased cleaved-caspase 3, TLR4, TRAF6, and nuclear NF-κB p65, alongside decreased XIAP and SOCS3.
  • Upregulation of miR-146a in IEC-6 cells enhanced cell survival, reduced apoptosis, and suppressed the TLR4/TRAF6/NF-κB pathway. This protective effect was abrogated by TRAF6 overexpression or increased NF-κB nuclear translocation.

Conclusions:

  • miR-146a plays a crucial protective role in mitigating intestinal epithelial cell damage during ischemia and I/R injury.
  • The protective mechanism involves the inhibition of the TLR4/TRAF6/NF-κB signaling pathway, leading to reduced apoptosis and enhanced cell survival.
  • Restoring miR-146a levels represents a potential therapeutic strategy for managing small intestine ischemia-reperfusion injury.